Home › Funds › Jones Hill Capital LP › TVTX
Jones Hill Capital LP position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
Jones Hill Capital LP reported holding 959,634 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$56.5M, representing 9.59% of its reported portfolio and ranking #3 among its reported holdings. Jones Hill Capital LP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's TVTX position evolved
Jones Hill Capital LP first disclosed a stake in TVTX in Q3 2026 at 959,634 shares (US$56.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 959.63K | $56.50M | New |
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.75M sh · $213.18M · Q2 2026
- Rock Springs Capital Management LP 2.18M sh · $123.79M · Q2 2026
- Kynam Capital Management, LP 2.00M sh · $113.62M · Q2 2026
- Stephens Investment Management Group LLC 1.88M sh · $110.50M · Q3 2026
- EMERALD ADVISERS, LLC 1.56M sh · $92.06M · Q3 2026
- Context Capital Management, LLC 62.70M sh · $73.14M · Q3 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 984.85K sh · $57.99M · Q3 2026
- Eversept Partners, LP 798.97K sh · $45.39M · Q2 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 28.00M sh · $32.96M · Q2 2026
- ARMISTICE CAPITAL, LLC 500.00K sh · $28.41M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held TVTX?
Jones Hill Capital LP has disclosed TVTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Jones Hill Capital LP's current position in TVTX?
As of Q3 2026, Jones Hill Capital LP holds 959.63K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $56.50M, representing 9.59% of its reported portfolio and ranking #3.
Has Jones Hill Capital LP been buying or selling TVTX?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP newly opened its position in TVTX.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.